Study of Alpha-glycerylphosphorylcholine (A-GPC) for Muscle Performance
This study is looking at how a single dose of Alpha-glycerylphosphorylcholine (A-GPC), a dietary supplement, affects lower body muscle performance in healthy, recreationally-trained young men. Researchers want to see if taking 900 mg of A-GPC improves muscle strength and activation compared to a placebo (Microcrystalline Cellulose). They will measure your maximal voluntary isometric contraction (how hard you can push or pull a muscle) and muscle activation about 90 minutes after you take the supplement. The study is looking for 20 participants between 19 and 29 years old. You cannot participate if you have certain health conditions, use medications or other nutritional supplements, or regularly consume caffeine. The current status of this study is unclear.
- Study design
- This is an interventional study, meaning participants will receive a specific treatment. It plans to enroll 20 healthy adult men.
- What's involved
- You would take a single oral dose of either Alpha-glycerylphosphorylcholine or a placebo. Muscle strength and activation will be measured approximately 90 minutes after taking the dose.
- Compensation
- Not stated in the trial record.
- Follow-up
- Measurements are taken approximately 90 minutes after ingestion, suggesting a short follow-up period.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Acute Effects of Alpha-glycerylphosphorylcholine (A-GPC) on Lower Body Muscular Performance.
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Clayton Camic, PHD · PRINCIPAL_INVESTIGATOR · Northern Illinois University
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Maximal Voluntary Isometric ContractionApproximately 90 minutes post-ingestion of condition
MVIC of leg extensors at 120 degrees between thigh and leg
- Muscle ActivationApproximately 90 minutes post ingestion
EMG amplitude during MVIC